Effect of inhaled corticosteroid on pulmonary injury and inflammatory mediator production after cardiopulmonary bypass in children

Pediatric Critical Care Medicine

Volumn 8, Issue 5, 2007, Pages 465-469

  Santos, Alexander R ^a   Heidemann, Sabrina M ^a   Walters III, Henry L ^b   Delius, Ralph E ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Acute lung injury; Cardiopulmonary bypass; Corticosteroid; Infants; Interleukin 6; Interleukin 8

Indexed keywords

BUDESONIDE; CORTICOSTEROID; INTERLEUKIN 6; INTERLEUKIN 8;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INFANT; LUNG COMPLIANCE; LUNG INJURY; LUNG LAVAGE; MALE; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; BRONCHOALVEOLAR LAVAGE FLUID; BUDESONIDE; CARDIOPULMONARY BYPASS; CHILD; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; LUNG COMPLIANCE; MALE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 34548692943     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000282169.11809.80     Document Type: Article

References (36)

1. Miller BE, Levy JH: The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11:355-366
2. Hill GE: Cardiopulmonary bypass-induced inflammation: Is it important? J Cardiothorac Vasc Anesth 1998; 12:21-25
3. Tsuchida M, Watanabe H, Watanabe T, et al: Effect of cardiopulmonary bypass on cytokine release and adhesion molecule expression in alveolar macrophages. Preliminary report in six cases. Am J Respir Crit Care Med 1997; 156:932-938
4. Wan S, LeClerc JL, Vincent JL: Cytokine responses to CPB: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-276
5. Baggioilini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 1994; 55:97-179
6. Gerard C, Rollins BJ: Chemokines and disease. Nat Immunol 2001; 2:108-115
7. Proudfoot AEI: Chemokine receptors: Multifaceted therapeutic targets. Nat Rev Immunol 2002; 2:106-115
8. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445
9. Ivey CL, Williams FM, Collins PD, et al: Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit: Evidence for a role for C5a and interleukin-8. J Clin Invest 1995; 95:2720-2728
10. Kilger E, Weis F, Briegel J, et al: Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-1074
11. McBride WT, Armstrong MA, Gilliland H, et al: The balance of pro- and anti-inflammatory cytokines in plasma and bronchoalveolar lavage at pediatric cardiac surgery. Cytokine 1996; 8:724-729
12. Wan S, LeClerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997; 112:676-692
13. Oberholzer A, Oberholzer C, Moldawer LL: Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med 2000; 28:N3-N12
14. Asimakopoulos G, Taylor KM, Haskard DO, et al: Inhibition of neutrophil L-selectin shedding: A potential anti-inflammatory effect of aprotinin. Perfusion 2000; 15:495-499
15. Lei Y, Husnain KH, Chusnheng HW, et al: Dose-dependent effect of aprotinin on aggravated pro-inflammatory cytokines in patient with pulmonary hypertension following cardiopulmonary bypass. Cardiovasc Drugs Ther 2003; 17:343-348
16. Gu YJ, van Oeveren W, Akkerman C, et al: Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55:917-922
17. te Velthuis H, Baufreton C, Jansen PG, et al: Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations. J Thorac Cardiovasc Surg 1997; 114:117-122
18. Brancaccio G, Villa E, Girolami E, et al: Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process. Perfusion 2005; 20:263-268
19. Sever K, Tansel T, Basaran M, et al: The benefits of continuous ultrafiltration in pediatric cardiac surgery. Scand Cardiovasc J 2004; 38:307-311
20. Chen YF, Tsai WC, Lin CC, et al: Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 2004; 78:634-643
21. Varan B, Tokel K, Mercan S, et al: Systemic inflammatory response related to cardiopulmonary bypass and its modification by methylprednisolone: High dose versus low dose. Pediatr Cardiol 2002; 23:437-441
22. Kotani N, Hashimoto H: Cardiopulmonary bypass greater pulmonary than systemic proinflammatory cytokines. Anesth Analg 2000; 90:1035-1045
23. Jenkins KJ, Gauvreau K, Newburger JW, et al: Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Sur 2002; 123:110-118
24. Azab SR, Rosseel PMJ, de Lange JJ, et al: Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anesth 2002; 88:496-501
25. Schroeder V, Pearl J, Schwartz S, et al: Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation 2003; 107:2823-2828
26. Celik J, Gormus N, Okesli S, et al: Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: Effects on TNF-α, IL-6, IL-8, IL-10. Perfusion 2004; 19:185-191
27. Anic D, Gasparovic H, Ivancan V, et al: Effects of corticosteroids on inflammatory response following cardiopulmonary bypass. Croat Med J, 2004; 45:158-161
28. Checchia P, Bronicki R, Costello J, et al: Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers. Pediatr Crit Care Med 2005; 6:441-444
29. Gessler P, Hohl V, Carrel T, et al: Administration of steroids in pediatric cardiac surgery: Impact on clinical outcome and systemic inflammatory response. Pediatr Cardiol 2005; 26:595-600
30. Morariu AM, Loef BG, Aarts L, et al: Dexamethasone: Benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting. Chest 2005; 128: 2677-2687
31. Whitlock RP, Noora YJ, Farrokhyar F, et al: Pulse low dose steroids attenuate postcardiopulmonary bypass SIRS; SIRS I. J Surg Res 2006; 132:188-194
32. Cole C: Special problems in aerosol delivery: Neonatal and pediatric considerations. Respir Care 2000; 45:646-651
33. Turpeinen M, Nikander K: Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit. Respir Care 2001; 46:43-48
34. Diego RP, Mihalakakos RJ, Hexum TD, et al: Methylprednisolone and full dose aprotinin reduce reperfusion injury after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 29-31
35. Kawamura T, Inada K, Nara N, et al: Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 1999; 27:545-548
36. Giomarelli P, Scoletta S, Borelli E, et al: Myocardial and lung injury after cardiopulmonary bypass: Role of interleukin-10. Ann Thorac Surg 2003; 76:117-123